4//SEC Filing
Resnick Joshua 4
Accession 0001493152-22-017507
CIK 0001798749other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:00 PM ET
Size
6.2 KB
Accession
0001493152-22-017507
Insider Transaction Report
Form 4
Resnick Joshua
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-21+12,500→ 12,500 totalExercise: $12.26Exp: 2032-06-20→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]The shares subject to this option will vest and become exercisable in full on the earlier of (i) June 21, 2023 or (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund, the Nexus Fund, and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001690959
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:00 PM ET
- Size
- 6.2 KB